Skip to content
Review Open access

Impact of Pharmacist-Led Polypharmacy Management on Prescribing Patterns in Older Inpatients: A Real-World Study in a Chronic Care Hospital.

Oct 2026 · Drugs - Real World Outcomes · 0 citations · 18 references
Medicine

TL;DR

It is suggested that pharmacist-led interventions in chronic care settings may contribute to reducing medication burden and modifying prescribing patterns beyond simple medication count reduction.

Abstract

Background

Polypharmacy is a major challenge in geriatric pharmacotherapy and is associated with increased risks of adverse drug events, functional decline, and increased healthcare costs. Although pharmacist-led medication reviews improve prescription appropriateness, evidence regarding the sustained implementation of such interventions in chronic care hospitals remains limited.

Objective

This study aimed to evaluate the impact of a stepwise pharmacist-led polypharmacy management program on prescription patterns and medication costs among older inpatients in a chronic care hospital.

Methods

We conducted a single-center, retrospective observational study at a chronic care hospital in Japan, and included all inpatients hospitalized between January 2023 and December 2025. A multidisciplinary polypharmacy management program was introduced in 2024, followed by pharmacist-led comprehensive medication evaluation and management in 2025. The study period was categorized into three phases: preintervention (2023), implementation (2024), and comprehensive management (2025). The primary outcome was the monthly average number of regularly prescribed oral medications. The secondary outcomes included the prevalence of polypharmacy, defined as the concurrent use of ≥ 6 regularly prescribed medications, and hyperpolypharmacy, defined as ≥ 10 medications. The threshold of ≥ 6 medications was adopted because it is used as the criterion for polypharmacy management in the Japanese national healthcare reimbursement system. The threshold of ≥ 10 medications corresponds to our hospital's institutional criterion for identifying patients eligible for pharmacist-led comprehensive medication review.

Results

Approximately 320 inpatients were included monthly during the study period. The average number of prescribed medications decreased from 6.44 ± 3.37 in 2023 to 6.23 ± 3.52 in 2024 and 6.05 ± 3.47 in 2025. Regarding the rate of polypharmacy, the proportion of patients taking ≥ 6 or ≥ 10 medications decreased from 54.3% to 46.5% and from 18.4% to 15.5%, respectively. In contrast, the total annual medication costs showed no significant changes across the 3 years. Analysis according to therapeutic class demonstrated decreased costs for hypnotics/anxiolytics and nonsteroidal antiinflammatory drugs/paracetamol, whereas antithrombotic drug costs increased. The prescription volume measured by defined daily dose per 100 patients per day (DPD) remained generally stable, although intergroup differences were observed in 2025.

Conclusions

Pharmacist-led polypharmacy management was associated with changes in prescribing patterns and reductions in medication burden in this chronic care hospital. However, the reductions in the number of medications did not translate into short-term reductions in medication costs. These findings suggest that pharmacist-led interventions in chronic care settings may contribute to reducing medication burden and modifying prescribing patterns beyond simple medication count reduction. These findings also highlight the importance of using multiple indicators when evaluating deprescribing strategies.

Read PDF

Similar papers

Review Open access Oct 2026

Prevalence, Prescribing Patterns, and Determinants of Polypharmacy among Geriatric Inpatients: A Retrospective Observational Study at a Tertiary Care Teaching Hospital

Background: Polypharmacy has become an important challenge in geriatric care owing to the high prevalence of multimorbidity and age-related physiological changes that increase susceptibility to medication-related harm. Hospitalized older adults are particularly vulnerable to adverse drug reactions, drug–drug interactio...

Arpit Verma, S. Prajapati, Brijesh Kumar Gupta et al. · 0 citations
Open access Nov 2026

A prospective observational study on geriatric and pediatric prescribing patterns, medication adherence, and cost analysis in a tertiary care hospital.

BACKGROUND Pediatric and geriatric patients are at risk of adverse drug effects as a consequence of age factors on pharmacokinetics, multimorbidity, and multicomplicated therapy regimens. The purpose of this study was to assess the quality of prescriptions as far as adherence and pharmacoeconomic burden are concerned i...

Vignesh Sivakumar, J. N. Varma, P. Srinivas et al. · 0 citations
Review Open access Oct 2026

Reducing Drug-Related Problems and Optimising Therapy in Older Adults with Polypharmacy: A Systematic Review of Community Pharmacy-Based Medication Reviews

Overall, pharmacist-led medication review appears to be a promising strategy to support safer and more appropriate medication use among older adults with polypharmacy, although further well-designed studies are needed to clarify long-term clinical, humanistic, and economic outcomes.

Favian Rafif Firdaus, Alsita Salsabila Yulnanda, H. Pramestutie · 0 citations
Review Open access Oct 2026

Polypharmacy and potentially inappropriate medication use in hospitalized geriatric patients: a prospective evaluation using the American geriatrics society 2023 Beers criteria

Background: Elderly inpatients are disproportionately burdened by polypharmacy and potentially inappropriate medication (PIM) use, driven by age-related pharmacokinetic change, multimorbidity, and fragmented prescribing. Systematic Beers criteria-based prescription review is rarely practised in Indian tertiary care set...

Sarfaraz M., R. Biradar, Khuteja Parveen · 0 citations
Review Open access Oct 2026

Evaluation of Drug-Related Problems and Pharmacist Interventions in Hospitalized Patients: A Prospective Observational Study

Elderly inpatients with polypharmacy and cardiovascular comorbidities represent the highest risk group for preventable DRPs, and proactive clinical pharmacist integration through daily ward rounds and medication reconciliation achieves a high rate of problem resolution, enhancing inpatient drug safety.

Anamika S. Patne, Shivakumar S. Ladde, Prajakta N. Sakhare et al. · 0 citations
Open access Oct 2026

Pharmacist-Led Comprehensive Medication Management and Patient Outcomes in Pediatric Intensive Care Unit Patients: A Multicenter Cohort Study

Objective: Clinical pharmacists improve medication management and safety in intensive care units, yet their role in neonatal and pediatric intensive care remains highly variable across institutions. Evidence supporting standardized clinical pharmacy practice models in these settings is limited. This study evaluated the...

K. Parbouni, K. Henry, M. Heavner et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.